199 related articles for article (PubMed ID: 25862495)
21. HMGA2 expression pattern and TERT mutations in tumors of the vulva.
Agostini A; Panagopoulos I; Andersen HK; Johannesen LE; Davidson B; Tropé CG; Heim S; Micci F
Oncol Rep; 2015 Jun; 33(6):2675-80. PubMed ID: 25823555
[TBL] [Abstract][Full Text] [Related]
22. TERT promoter mutations are associated with poor prognosis in cutaneous squamous cell carcinoma.
Campos MA; Macedo S; Fernandes M; Pestana A; Pardal J; Batista R; Vinagre J; Sanches A; Baptista A; Lopes JM; Soares P
J Am Acad Dermatol; 2019 Mar; 80(3):660-669.e6. PubMed ID: 30165166
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical and mutational status of telomerase reverse transcriptase in conjunctival squamous cell carcinoma.
Jayaraj P; Sen S; Saxena K; Gupta J; Vats P; Kashyap S; Chauhan S; Pushker N
Indian J Ophthalmol; 2022 Mar; 70(3):971-975. PubMed ID: 35225554
[TBL] [Abstract][Full Text] [Related]
24. High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.
Nguyen D; Taheri D; Springer S; Cowan M; Guner G; Mendoza Rodriguez MA; Wang Y; Kinde I; VandenBussche CJ; Olson MT; Ricardo BF; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
Virchows Arch; 2016 Oct; 469(4):427-34. PubMed ID: 27520411
[TBL] [Abstract][Full Text] [Related]
25. Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.
Palsgrove DN; Taheri D; Springer SU; Cowan M; Guner G; Mendoza Rodriguez MA; Rodriguez Pena MDC; Wang Y; Kinde I; Ricardo BFP; Cunha I; Fujita K; Ertoy D; Kinzler KW; Bivalacqua TJ; Papadopoulos N; Vogelstein B; Netto GJ
Hum Pathol; 2019 Mar; 85():1-9. PubMed ID: 30447301
[TBL] [Abstract][Full Text] [Related]
26. Benign and Malignant Brenner Tumors Show an Absence of TERT Promoter Mutations That Are Commonly Present in Urothelial Carcinoma.
Khani F; Diolombi ML; Khattar P; Huang W; Fallon JT; Epstein JI; Zhong M
Am J Surg Pathol; 2016 Sep; 40(9):1291-5. PubMed ID: 27299795
[TBL] [Abstract][Full Text] [Related]
27. Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma.
Heidenreich B; Nagore E; Rachakonda PS; Garcia-Casado Z; Requena C; Traves V; Becker J; Soufir N; Hemminki K; Kumar R
Nat Commun; 2014 Feb; 5():3401. PubMed ID: 24569790
[TBL] [Abstract][Full Text] [Related]
28. Genomic characterization of small cell carcinomas of the uterine cervix.
Schultheis AM; de Bruijn I; Selenica P; Macedo GS; da Silva EM; Piscuoglio S; Jungbluth AA; Park KJ; Klimstra DS; Wardelmann E; Hartmann W; Gerharz CD; von Petersdorff M; Buettner R; Reis-Filho JS; Weigelt B
Mol Oncol; 2022 Feb; 16(4):833-845. PubMed ID: 33830625
[TBL] [Abstract][Full Text] [Related]
29. Telomeres and Telomerase in Cutaneous Squamous Cell Carcinoma.
Ventura A; Pellegrini C; Cardelli L; Rocco T; Ciciarelli V; Peris K; Fargnoli MC
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30884806
[TBL] [Abstract][Full Text] [Related]
30. Frequency of telomerase reverse transcripter promoter mutations in desmoplastic melanoma subtypes: analyses of 76 cases.
Yang S; Leone D; Frydenlund N; Hoang M; Deng A; Hernandez-Perez M; Biswas A; Singh R; Yaar R; Mahalingam M
Melanoma Res; 2016 Aug; 26(4):361-6. PubMed ID: 27244099
[TBL] [Abstract][Full Text] [Related]
31. Telomerase reverse transcriptase (TERT) promoter mutations in primary adenocarcinoma of bladder and urothelial carcinoma with glandular differentiation: pathogenesis and diagnostic implications.
Cheng L; Lopez-Beltran A; Wang M; Montironi R; Kaimakliotis HZ; Zhang S
Mod Pathol; 2021 Jul; 34(7):1384-1391. PubMed ID: 33674765
[TBL] [Abstract][Full Text] [Related]
32. Implications of TERT promoter mutations and telomerase activity in urothelial carcinogenesis.
Günes C; Wezel F; Southgate J; Bolenz C
Nat Rev Urol; 2018 Jun; 15(6):386-393. PubMed ID: 29599449
[TBL] [Abstract][Full Text] [Related]
33. TERT promoter mutations in skin cancer: the effects of sun exposure and X-irradiation.
Pópulo H; Boaventura P; Vinagre J; Batista R; Mendes A; Caldas R; Pardal J; Azevedo F; Honavar M; Guimarães I; Manuel Lopes J; Sobrinho-Simões M; Soares P
J Invest Dermatol; 2014 Aug; 134(8):2251-2257. PubMed ID: 24691053
[TBL] [Abstract][Full Text] [Related]
34. Allelic losses at chromosome 3p are seen in human papilloma virus 16 associated transitional cell carcinoma of the cervix.
Maitra A; Wistuba II; Gibbons D; Gazdar AF; Albores-Saavedra J
Gynecol Oncol; 1999 Sep; 74(3):361-8. PubMed ID: 10479494
[TBL] [Abstract][Full Text] [Related]
35.
Yu Y; Fan D; Song X; Zakeri K; Chen L; Kang J; McBride S; Tsai CJ; Dunn L; Sherman E; Katabi N; Dogan S; Cracchiolo J; Cohen M; Boyle JO; Lee M; Valero C; Wang J; Wong R; Morris L; Riaz N; Lee N
JCO Precis Oncol; 2021 Aug; 5():. PubMed ID: 34381934
[TBL] [Abstract][Full Text] [Related]
36. Precise Classification of Cervical Carcinomas Combined with Somatic Mutation Profiling Contributes to Predicting Disease Outcome.
Spaans VM; Trietsch MD; Peters AA; Osse M; Ter Haar N; Fleuren GJ; Jordanova ES
PLoS One; 2015; 10(7):e0133670. PubMed ID: 26197069
[TBL] [Abstract][Full Text] [Related]
37. Frequent DPH3 promoter mutations in skin cancers.
Denisova E; Heidenreich B; Nagore E; Rachakonda PS; Hosen I; Akrap I; Traves V; García-Casado Z; López-Guerrero JA; Requena C; Sanmartin O; Serra-Guillén C; Llombart B; Guillén C; Ferrando J; Gimeno E; Nordheim A; Hemminki K; Kumar R
Oncotarget; 2015 Nov; 6(34):35922-30. PubMed ID: 26416425
[TBL] [Abstract][Full Text] [Related]
38. Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia.
Papathomas TG; Oudijk L; Zwarthoff EC; Post E; Duijkers FA; van Noesel MM; Hofland LJ; Pollard PJ; Maher ER; Restuccia DF; Feelders RA; Franssen GJ; Timmers HJ; Sleijfer S; de Herder WW; de Krijger RR; Dinjens WN; Korpershoek E
Endocr Relat Cancer; 2014 Aug; 21(4):653-61. PubMed ID: 24951106
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
40. TERT promoter mutations in familial and sporadic melanoma.
Horn S; Figl A; Rachakonda PS; Fischer C; Sucker A; Gast A; Kadel S; Moll I; Nagore E; Hemminki K; Schadendorf D; Kumar R
Science; 2013 Feb; 339(6122):959-61. PubMed ID: 23348503
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]